Shah Preetam 4
4 · Cidara Therapeutics, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Award
Common Stock
2022-03-31+51,250→ 71,250 total - Tax Payment
Common Stock
2022-03-31$0.83/sh−24,820$20,601→ 112,431 total - Award
Employee Stock Option (right to buy)
2022-03-31+102,500→ 102,500 totalExercise: $0.83Exp: 2032-03-30→ Common Stock (102,500 underlying) - Award
Common Stock
2022-03-31+66,001→ 137,251 total
Footnotes (4)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
- [F2]Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date.
- [F3]Shares withheld for taxes on RSU vesting.
- [F4]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.